2.12
Schlusskurs vom Vortag:
$2.06
Offen:
$2.065
24-Stunden-Volumen:
21,582
Relative Volume:
0.47
Marktkapitalisierung:
$7.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$2.81M
KGV:
-0.1477
EPS:
-14.3497
Netto-Cashflow:
$7.14M
1W Leistung:
+0.95%
1M Leistung:
-9.01%
6M Leistung:
-36.53%
1J Leistung:
-41.76%
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Firmenname
Kiora Pharmaceuticals Inc
Sektor
Branche
Telefon
858-224-9600
Adresse
169 SAXONY RD., ENCINITAS
Vergleichen Sie KPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
KPRX
Kiora Pharmaceuticals Inc
|
2.12 | 7.58M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kiora Pharmaceuticals Inc Aktie (KPRX) Neueste Nachrichten
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.5% – Should You Sell? - Defense World
Will Kiora Pharmaceuticals Inc. (7EY) stock beat Nasdaq index returnsQuarterly Trade Report & Proven Capital Preservation Methods - Newser
How Kiora Pharmaceuticals Inc. (7EY) stock reacts to new regulationsJuly 2025 Recap & Expert Approved Momentum Ideas - Newser
Is Kiora Pharmaceuticals Inc. (7EY) stock cheap vs fundamentalsJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - Newser
Will Kiora Pharmaceuticals Inc. stock benefit from commodity prices2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Kiora Pharmaceuticals receives new patent for KIO-100 formulations By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives new patent for KIO-100 formulations - Investing.com
Kiora Pharma (NASDAQ: KPRX) wins US patent amid Phase 2 KIO-104 eye study - Stock Titan
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds - Yahoo Finance
Is Kiora Pharmaceuticals Inc. stock overvalued by current metricsTrade Exit Report & Community Trade Idea Sharing - BỘ NỘI VỤ
Is Kiora Pharmaceuticals Inc. stock a defensive play in 2025Gap Up & Daily Entry Point Trade Alerts - BỘ NỘI VỤ
What drives Kiora Pharmaceuticals Inc stock priceConsumer Goods Stocks & Free Daily Top Stock Picks for All Investors - earlytimes.in
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema? - MSN
What analyst consensus implies for Kiora Pharmaceuticals Inc. (7EY) stock2025 Market WrapUp & High Accuracy Trade Signal Alerts - newser.com
Can Kiora Pharmaceuticals Inc. stock resist sector downturnsMarket Activity Report & Daily Profit Focused Screening - newser.com
Can Kiora Pharmaceuticals Inc. stock resist market sell offsFed Meeting & Real-Time Chart Pattern Alerts - newser.com
Will Kiora Pharmaceuticals Inc. stock outperform growth indexes2025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
Why Kiora Pharmaceuticals Inc. (7EY) stock signals breakout potentialTrade Exit Summary & Expert Curated Trade Ideas - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.Quarterly Investment Review & Entry and Exit Point Strategies - newser.com
How moving averages guide Kiora Pharmaceuticals Inc. trading2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probabilityJuly 2025 Update & High Yield Stock Recommendations - newser.com
How to track smart money flows in Kiora Pharmaceuticals Inc.Gap Down & Weekly Market Pulse Alerts - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Using data filters to optimize entry into Kiora Pharmaceuticals Inc.Earnings Growth Summary & Weekly Market Pulse Updates - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitorsGDP Growth & Stock Portfolio Risk Control - newser.com
Published on: 2025-11-19 14:22:52 - newser.com
When is the best time to exit Kiora Pharmaceuticals Inc.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Why global investors buy Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
What candlestick patterns are forming on Kiora Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
Published on: 2025-11-17 02:08:28 - newser.com
What analysts say about Kiora Pharmaceuticals Inc stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):